GoogleNews Aggregator

A Service of Remembrance will follow. In lieu of flowers, donations may be made in Mary's memory to the Huntington's Disease Society of America at:Read more

In place of flowers, donations may be made to the Huntington's Disease Society of America, the Hereditary Disease Foundation, or the Huntington Study ...Read more

Huntington's is caused by mutations in the HTT gene that lead to the production of muHTT. This abnormal protein misfolds and accumulates inside nerve ...Read more

Andrew Wilner interviews Victor Sung about a phase 1/2 trial on AMT-130, an investigational gene therapy for Huntington disease.Read more

... Huntington's disease. Never Miss a Headline. Set us as a Preferred ... Windtree Therapeutics cardiovascular disease Alzheimer's disease pipeline biotech ...Read more

In more hopeful news, September saw an announcement that sent shockwaves through Huntington's disease community. For the first time, an ...Read more

... disease-related proteins in cerebral spinal fluid including SNAP25 ... In addition, data from a randomized Phase 2 study in Huntington's disease ...Read more

Huntington's disease occurs due to a genetic mutation that, over time, kills brain cells — leading to difficulties with movement, thinking, and mood.Read more

... disorder that affects body ... disorders with uncontrollable movements: tardive dyskinesia and chorea associated with Huntington's disease.Read more

Along with his new career, Mr Martinez hopes to promote discussion around Huntington's Disease, a genetic disorder present in his family. The ...Read more

Neurocrine markets Ingrezza in tardive dyskinesia and chorea associated with Huntington's disease. Product sales rose 12% to $687 million in the ...Read more

Additional data from a randomized Phase 2 Huntington's disease study and the completed SIGNAL-AD trial suggest the antibody was well tolerated and ...Read more

... disease progression in Alzheimer's and Huntington's disease. Collaboration with industry experts, such as Dr. Philip De Jager, adds credibility to ...Read more

In addition, data from a randomized Phase 2 study in Huntington's disease (HD, n=179) as well as the completed SIGNAL-AD phase 1/2a study in Mild ...Read more

... Huntington's disease through the inhibition of semaphorin 4D (SEMA4D). The Company's lead drug candidate, pepinemab, blocks SEMA4D, a potent ...Read more